نتایج جستجو برای: vinblastine

تعداد نتایج: 3670  

Journal: :Cancer research 1975
A Krishan E Frei

Exposure of human leukemic lymphoblasts in suspension cultures to low concentrations of vinblastine and vincristine results in alterations in cell shape and leads to the formation and release of a large number of membrane-lined vesicles from the cytoplasm. Separation of these vesicles from peripheral cytoplasm is effected through alignment and fusion of small vacoules. Similar vesicle formation...

2010
A Cingolani L Torti C Pinnetti K de Gaetano Donati1 R Murri E Tacconelli LM Larocca L Teofili

In order to analyze the clinical relevance of the pharmacokinetic interactions between vinblastine and antiretrovirals described in literature, we evaluated all HIV-infected patients with Hodgkin's lymphoma treated with vinblastine-containing regimens and combination antiretroviral therapy, in a single clinical center. The use of protease inhibitors was independently associated with WHO grade I...

Journal: :British Journal of Clinical Pharmacology 1977

Journal: :Brazilian Archives of Biology and Technology 2022

HIGHLIGHTS Melanoma is a cancer with poor prognosis, and metastasis. Curcumin compound many beneficial effects regarding prevention adjuvant treatment of Vinblastine curcumin greatly promoted production ROS in melanoma cells disrupted adenosine formation cascade, reducing imunosupression at tumoral site.

Journal: :Molecular pharmacology 2000
P Verdier-Pinard J A Kepler G R Pettit E Hamel

Dolastatin 10 is a highly cytotoxic antimitotic peptide in phase II clinical trials. Its cytotoxicity has been as much as 50-fold greater than that of vinblastine, despite quantitatively similar effects of the two drugs on tubulin polymerization. We compared uptake and efflux of radiolabeled dolastatin 10 and vinblastine in human Burkitt lymphoma CA46 cells to gain an understanding of the great...

Journal: :Molecular cancer therapeutics 2013
Darcy J P Bates Alexey V Danilov Christopher H Lowrey Alan Eastman

Proteins of the BCL2 family provide a survival mechanism in many human malignancies, including chronic lymphocytic leukemia (CLL). The BCL2 inhibitor ABT-263 (navitoclax) is active in clinical trials for lymphoid malignancies, yet resistance is expected on the basis of preclinical models. We recently showed that vinblastine can dramatically sensitize several leukemia cell lines to ABT-737 (the ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Danilo Marimpietri Chiara Brignole Beatrice Nico Fabio Pastorino Annalisa Pezzolo Federica Piccardi Michele Cilli Daniela Di Paolo Gabriella Pagnan Luca Longo Patrizia Perri Domenico Ribatti Mirco Ponzoni

PURPOSE Vinblastine and rapamycin displayed synergistic inhibition of human neuroblastoma-related angiogenesis. Here, we studied the antitumor activity of vinblastine and rapamycin against human neuroblastoma. EXPERIMENTAL DESIGN Cell proliferation, cell cycle progression, and apoptosis were evaluated by measuring (3)H-thymidine incorporation, bromodeoxyuridine uptake, and phosphatidylserine ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Dave Cervi Giannoula Klement Diana Stempak Sylvain Baruchel Alane Koki Yaacov Ben-David

PURPOSE To test the efficacy of selective therapy against cyclooxygenase-2 in combination with a low-dose regimen of a cytotoxic agent in the treatment of juvenile hematopoietic malignancies in the experimental model, Friend disease. EXPERIMENTAL DESIGN Juvenile erythroleukemic mice (n = 8) received no treatment, celecoxib (1600 mg/kg/d), vinblastine (0.5 microg/g twice weekly), vehicle contr...

Journal: :Molecular pharmacology 2006
Donnette A Dabydeen James C Burnett Ruoli Bai Pascal Verdier-Pinard Sarah J H Hickford George R Pettit John W Blunt Murray H G Munro Rick Gussio Ernest Hamel

The complex marine natural product halichondrin B was compared with NSC 707389 (E7389), a structurally simplified, synthetic macrocyclic ketone analog, which has been selected for clinical trials in human patients. NSC 707389 was invariably more potent than halichondrin B in its interactions with tubulin. Both compounds inhibited tubulin assembly, inhibited nucleotide exchange on beta-tubulin, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید